Take a look back at CURE®’s Educated Patient® Lung Cancer Summit with this roundup of stories that highlight what was discussed at this half-day virtual event.
Supportive care, molecular testing, specialized care — attendees at CURE®'s Educated Patient® Lung Cancer Summit were treated to presentations from experts in all of these fields and more, Saturday, March 6th. This half-day virtual event brought together patients, survivors, caregivers and healthcare professionals from around the lung cancer community to discuss the latest in lung cancer updates, research and education.
If you missed it live, you can view the entire summit here, or read our conference coverage below.
A number of current studies evaluating the efficacy of adoptive cellular therapies may one day offer patients with non-small cell lung cancer a “high risk, high reward” treatment option, according to Dr. Ben Creelan of the Moffitt Cancer Center.
As the population ages, the incidence of older adults being diagnosed with lung cancer is increasing, though data on how to specifically treat this population are lacking, says Dr. Efrat Dotan of Fox Chase Cancer Center.
Dr. Taofeek K. Owonikoko, of Emory University, examines how small cell lung cancer is diagnosed; how it's treated; how to pivot if the disease spreads or recurs; and how clinical trials can potentially treat patients more effectively.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.